EPISODE · Jun 9, 2022 · 37 MIN
4.67 Teclistimab for R/R Multiple Myeloma
from Plenary Session - inactive due to federal service · host Plenary Session
The drug has a high response rate and lots of infections, is it active? Yes; Efficacious? ???? I review ASCO2022 updates
What this episode covers
The drug has a high response rate and lots of infections, is it active? Yes; Efficacious? ???? I review ASCO2022 updates
NOW PLAYING
4.67 Teclistimab for R/R Multiple Myeloma
0:00
37:42
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Plenary Session - inactive due to federal service?
This episode is 37 minutes long.
When was this Plenary Session - inactive due to federal service episode published?
This episode was published on June 9, 2022.
What is this episode about?
The drug has a high response rate and lots of infections, is it active? Yes; Efficacious? ???? I review ASCO2022 updates
Can I download this Plenary Session - inactive due to federal service episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!